Financial Year |
March 31 2023 |
Monetary Funds |
945,288,379.20 |
Held-for-trading Financial Assets |
300,000,000.00 |
Notes Receivable |
15,953,550.57 |
Accounts Receivable |
985,786,171.35 |
Advances to Suppliers |
11,938,114.50 |
Other Receivables |
24,574,547.51 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
282,658,086.33 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
257,849,567.44 |
Other Current Assets |
5,073,743.93 |
Total Current Assets |
3,173,391,910.28 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
26,298,213.75 |
Long-term Equity Investment |
12,495,579.09 |
Investment Properties |
85,794,621.36 |
Fixed Assetes |
378,533,278.45 |
Under-construction Projects |
20,818,108.68 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
246,768,961.65 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
1,148,122.41 |
Deferred Income Tax Assets |
138,627,851.51 |
Other Non-Current Assets |
11,597,528.39 |
Sub-Total of Non-Current Assets |
1,359,147,382.52 |
Total Assets |
4,532,539,292.80 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
331,889,589.20 |
Accounts Payable |
547,577,130.24 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
208,550,083.28 |
Taxes Payable |
109,197,308.85 |
Interest Payable |
-- |
Dividend Payable |
1,830,852.80 |
Other payables |
270,529,245.34 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
381,712.71 |
Other Current Liabilities |
41,359,112.57 |
Sub-Total of Current Liabilities |
1,567,409,315.42 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
1,040,083.29 |
Special Payable |
-- |
Estimatied Liabilities |
153,391,590.77 |
Deferred Income Tax Liabilities |
87,895,194.40 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
304,554,000.46 |
Total Liabilities |
1,871,963,315.88 |
Paid-In Capital(Or Share Stock) |
546,180,037.00 |
Capital Surplus |
1,051,833,413.84 |
Surplus Reserve |
299,245,514.10 |
LESS:Treasury Stock |
161,974,621.20 |
Undistributed Profits |
693,646,009.78 |
Minority Stockholder's Interest |
199,764,667.19 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,460,811,309.73 |
Owner's Equity(Stockholder's Equity) |
2,660,575,976.92 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,532,539,292.80 |